Dowling & Yahnke’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6.5M | Buy |
68,136
+867
| +1% | +$85.8K | 0.3% | 84 |
|
|
2022
Q2 | $6.23M | Buy |
67,269
+735
| +1% | +$71.7K | 0.29% | 91 |
|
|
2022
Q1 | $6.73M | Buy |
66,534
+1,858
| +3% | +$195K | 0.29% | 92 |
|
|
2021
Q4 | $6.67M | Buy |
64,676
+1,826
| +3% | +$169K | 0.32% | 93 |
|
|
2021
Q3 | $5.33M | Buy |
62,850
+706
| +1% | +$59.1K | 0.3% | 100 |
|
|
2021
Q2 | $5.18M | Buy |
62,144
+2,392
| +4% | +$196K | 0.3% | 97 |
|
|
2021
Q1 | $4.5M | Buy |
59,752
+144
| +0.2% | +$10.5K | 0.31% | 96 |
|
|
2020
Q4 | $4.07M | Sell |
59,608
-205
| -0.3% | -$13.3K | 0.29% | 94 |
|
|
2020
Q3 | $3.49M | Sell |
59,813
-926
| -2% | -$57.6K | 0.28% | 97 |
|
|
2020
Q2 | $3.95M | Buy |
60,739
+6,474
| +12% | +$408K | 0.33% | 93 |
|
|
2020
Q1 | $3.22M | Sell |
54,265
-2,241
| -4% | -$150K | 0.31% | 95 |
|
|
2019
Q4 | $4.2M | Buy |
56,506
+1,330
| +2% | +$93.4K | 0.32% | 93 |
|
|
2019
Q3 | $3.48M | Buy |
55,176
+608
| +1% | +$36K | 0.29% | 102 |
|
|
2019
Q2 | $2.97M | Sell |
54,568
-1,703
| -3% | -$91.7K | 0.25% | 113 |
|
|
2019
Q1 | $3.04M | Sell |
56,271
-13,081
| -19% | -$807K | 0.29% | 96 |
|
|
2018
Q4 | $5.56M | Buy |
69,352
+5,361
| +8% | +$400K | 0.58% | 56 |
|
|
2018
Q3 | $5.04M | Sell |
63,991
-22
| -0% | -$1.57K | 0.44% | 76 |
|
|
2018
Q2 | $4.12M | Buy |
64,013
+1,573
| +3% | +$104K | 0.38% | 84 |
|
|
2018
Q1 | $3.88M | Sell |
62,440
-1,903
| -3% | -$137K | 0.36% | 89 |
|
|
2017
Q4 | $4.67M | Sell |
64,343
-2,504
| -4% | -$182K | 0.42% | 80 |
|
|
2017
Q3 | $5.44M | Sell |
66,847
-3,005
| -4% | -$238K | 0.55% | 66 |
|
|
2017
Q2 | $5.62M | Sell |
69,852
-1,021
| -1% | -$80.6K | 0.59% | 56 |
|
|
2017
Q1 | $5.56M | Sell |
70,873
-545
| -0.8% | -$43.5K | 0.59% | 58 |
|
|
2016
Q4 | $5.64M | Buy |
71,418
+419
| +0.6% | +$33.9K | 0.63% | 52 |
|
|
2016
Q3 | $6.32M | Sell |
70,999
-218
| -0.3% | -$20.6K | 0.74% | 40 |
|
|
2016
Q2 | $6.82M | Buy |
71,217
+1,479
| +2% | +$147K | 0.82% | 27 |
|
|
2016
Q1 | $7.23M | Buy |
69,738
+3,459
| +5% | +$336K | 0.89% | 25 |
|
|
2015
Q4 | $6.48M | Sell |
66,279
-332
| -0.5% | -$32.5K | 0.81% | 32 |
|
|
2015
Q3 | $6.43M | Sell |
66,611
-765
| -1% | -$80.4K | 0.88% | 24 |
|
|
2015
Q2 | $7.07M | Sell |
67,376
-1,286
| -2% | -$131K | 0.89% | 20 |
|
|
2015
Q1 | $7.09M | Sell |
68,662
-860
| -1% | -$87K | 0.89% | 19 |
|
|
2014
Q4 | $6.7M | Sell |
69,522
-1,414
| -2% | -$125K | 0.83% | 22 |
|
|
2014
Q3 | $5.65M | Sell |
70,936
-1,025
| -1% | -$80.8K | 0.74% | 34 |
|
|
2014
Q2 | $5.42M | Sell |
71,961
-2,171
| -3% | -$164K | 0.7% | 40 |
|
|
2014
Q1 | $5.55M | Sell |
74,132
-696
| -0.9% | -$49.2K | 0.73% | 35 |
|
|
2013
Q4 | $5.36M | Buy |
74,828
+572
| +0.8% | +$36.8K | 0.75% | 36 |
|
|
2013
Q3 | $4.21M | Sell |
74,256
-451
| -0.6% | -$26.9K | 0.66% | 50 |
|
|
2013
Q2 | $4.27M | Buy |
+74,707
| New | +$4.33M | 0.71% | 43 |
|
Other funds holding CVS
Dowling & Yahnke's CVS Position: Q3 2022 in Review
Dowling & Yahnke increased its CVS Health (CVS) stake by 1.3% in Q3 2022, buying an estimated $85.8K and bringing the position to 68,136 shares worth $6.5M. The position accounts for 0.3% of the portfolio, ranked #84.
Dowling & Yahnke first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $7.23M in Q1 2016. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- Dowling & Yahnke held 68,136 shares of CVS Health worth $6.5M as of Q3 2022.
- Dowling & Yahnke bought 867 CVS Health shares in Q3 2022, an estimated $85.8K.
- CVS Health made up 0.3% of Dowling & Yahnke's portfolio in Q3 2022, its #84 holding.
- Dowling & Yahnke first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's CVS Health position peaked at $7.23M in Q1 2016.
- 2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.